Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Vibhudutta Awasthi and Hooman Yari.
Vibhudutta Awasthi
Connection Strength
1.827
Hooman Yari
  1. Nanoparticles for Targeting of Prostate Cancer. Curr Pharm Des. 2020; 26(42):5393-5413.
    View in: PubMed
    Score: 0.704
  2. Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer. Materials (Basel). 2019 Mar 05; 12(5).
    View in: PubMed
    Score: 0.665
  3. Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome. Front Chem. 2018; 6:392.
    View in: PubMed
    Score: 0.161
  4. Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24. Am J Physiol Gastrointest Liver Physiol. 2018 08 01; 315(2):G318-G327.
    View in: PubMed
    Score: 0.157
  5. Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method. J Pharm Anal. 2017 Feb; 7(1):1-9.
    View in: PubMed
    Score: 0.140
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.